Alector, Inc. (ALEC) vs Allogene Therapeutics, Inc. (ALLO)

• Alector, Inc. ALEC 2.78 ▲ +9.88%
• Allogene Therapeutics, Inc. ALLO 0.90 ▼ −3.23%

Alector, Inc. and Allogene Therapeutics, Inc. are both Biotechnology companies. Alector, Inc. is the larger, with a market value of $376.7M against $322.9M — 1.2× the size. Allogene Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 7.1×. Allogene Therapeutics, Inc. grew revenue faster over the last twelve months: 7,613.1% against 151.2%. Alector, Inc. has the higher net margin (23.9% vs 0.00%) and the higher return on invested capital (0.00% vs −119.4%). Across the 15 metrics below, Alector, Inc. leads on 8 and Allogene Therapeutics, Inc. on 7.